ES2114722T3 - Procedimiento para preparar intermedios derivados del acido benzoico y agentes farmaceuticos benzotiofenos. - Google Patents

Procedimiento para preparar intermedios derivados del acido benzoico y agentes farmaceuticos benzotiofenos.

Info

Publication number
ES2114722T3
ES2114722T3 ES95306053T ES95306053T ES2114722T3 ES 2114722 T3 ES2114722 T3 ES 2114722T3 ES 95306053 T ES95306053 T ES 95306053T ES 95306053 T ES95306053 T ES 95306053T ES 2114722 T3 ES2114722 T3 ES 2114722T3
Authority
ES
Spain
Prior art keywords
benzotiofen
procedure
benzoic acid
pharmaceutical agents
preparing intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95306053T
Other languages
English (en)
Inventor
Douglas Patton Kjell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2114722T3 publication Critical patent/ES2114722T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Steroid Compounds (AREA)

Abstract

LA INVENCION SUMINISTRA UN NUEVO PROCESO PARA PREPARAR UN COMPUESTO DE LA FORMULA (I) EN LA QUE R ES ALQUILO C{SUB, 1-4}; R1 Y R2 SON CADA UNA INDEPENDIENTEMENTE ALQUILO C{SUB, 1-4}, O SE COMBINAN PARA FORMAR PIPERIDINILO, PIRROLIDINILO, METILPIRROLIDINO, DIMETILPIRROLIDINO, MORFOLINO, DIMETILAMINO, DIETILAMINO, O 1-HEXAMETILENOIMINO; Y N ES 2 O 3; TAMBIEN SE PRESENTAN UNA SAL FARMACOLOGICAMENTE ACEPTABLE DEL COMPUESTO. EL PRODUCTO DEL PROCESO, UN COMPUESTO DE LA FORMULA (I), ES TAMBIEN NUEVO Y ES UTIL PARA LA PREPARACION DE COMPUESTOS FARMACOLOGICAMENTE ACTIVOS DE LA FORMULA (II), PARTICULARMENTE POR MEDIO DEL PROCESO PRESENTADO.
ES95306053T 1994-08-31 1995-08-30 Procedimiento para preparar intermedios derivados del acido benzoico y agentes farmaceuticos benzotiofenos. Expired - Lifetime ES2114722T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/298,891 US5731436A (en) 1994-08-31 1994-08-31 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Publications (1)

Publication Number Publication Date
ES2114722T3 true ES2114722T3 (es) 1998-06-01

Family

ID=23152424

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95306053T Expired - Lifetime ES2114722T3 (es) 1994-08-31 1995-08-30 Procedimiento para preparar intermedios derivados del acido benzoico y agentes farmaceuticos benzotiofenos.

Country Status (15)

Country Link
US (2) US5731436A (es)
EP (1) EP0699673B1 (es)
JP (1) JPH08119912A (es)
KR (1) KR960007544A (es)
AT (1) ATE165356T1 (es)
BR (1) BR9503847A (es)
CA (1) CA2157235A1 (es)
DE (1) DE69502153T2 (es)
DK (1) DK0699673T3 (es)
ES (1) ES2114722T3 (es)
FI (1) FI954068A7 (es)
GR (1) GR3026743T3 (es)
HU (1) HUT73136A (es)
IL (3) IL126593A0 (es)
TW (1) TW368497B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5731436A (en) * 1994-08-31 1998-03-24 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents
CA2213810C (en) * 1996-08-29 2006-06-06 Lewis Dale Pennington Benzo¬b|thiophene compounds, intermediates, processes, compositions and methods
US5948796A (en) * 1996-10-10 1999-09-07 Eli Lilly And Company Benzo B!thiophene compounds, intermediates, formulations, and methods
WO1998046588A2 (en) 1997-04-11 1998-10-22 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
US6017914A (en) * 1997-09-03 2000-01-25 Eli Lilly And Company Benzo[b]thiophene compounds, intermediates, formulations, and methods
FR2817865B1 (fr) * 2000-12-11 2005-02-18 Sanofi Synthelabo Derive aminoalkoxybenzoyle sous forme de sel, son procede de preparation et son utilisation comme intermediaire de synthese
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
EP1832583A1 (en) 2002-09-30 2007-09-12 A/S GEA Farmaceutisk Fabrik Novel raloxifene sulphuric acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these
JP5603019B2 (ja) * 2008-03-26 2014-10-08 帝人株式会社 植物由来成分を有するポリエステルおよびその製造方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864501A (en) * 1973-10-10 1975-02-04 Us Agriculture Method of enhancing coloration of fruits and vegetables with a dialhylamino-alkoxybenzene
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
IL65379A0 (en) * 1981-04-03 1982-05-31 Lilly Co Eli Process for preparing acylated benzothiophenes
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
KR970006890B1 (ko) * 1987-10-20 1997-04-30 오스카 세이야꾸 가부시끼가이샤 페닐카르복시산 유도체 및 그 염
JPH02101048A (ja) * 1988-10-07 1990-04-12 Fuji Photo Film Co Ltd サリチル酸誘導体の製造方法
US5731436A (en) * 1994-08-31 1998-03-24 Eli Lilly And Company Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents

Also Published As

Publication number Publication date
US5731436A (en) 1998-03-24
TW368497B (en) 1999-09-01
KR960007544A (ko) 1996-03-22
IL115091A0 (en) 1995-12-08
IL115091A (en) 2000-08-31
IL126593A (en) 2000-08-31
DK0699673T3 (da) 1998-10-07
DE69502153T2 (de) 1998-09-17
FI954068A7 (fi) 1996-03-01
FI954068A0 (fi) 1995-08-30
EP0699673B1 (en) 1998-04-22
BR9503847A (pt) 1996-09-17
HU9502539D0 (en) 1995-10-30
ATE165356T1 (de) 1998-05-15
HUT73136A (en) 1996-06-28
EP0699673A1 (en) 1996-03-06
US5955608A (en) 1999-09-21
GR3026743T3 (en) 1998-07-31
CA2157235A1 (en) 1996-03-01
JPH08119912A (ja) 1996-05-14
DE69502153D1 (de) 1998-05-28
IL126593A0 (en) 1999-08-17

Similar Documents

Publication Publication Date Title
UY24409A1 (es) Inhibidores de la matriz metaloproteasa
LU90011I2 (fr) Remifentanil facultativement sous la forme d'un sel d'addition d'acide pharmaceutiquement acceptable y compris le chlorhydrate de remifentanil
AR017021A1 (es) Acido 2-hidroxiacetico
FR2662162B1 (fr) Nouveaux derives de l'amino piperidine, de l'amino pyrrolidine et de l'amino perhydroazepine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
EA200301306A1 (ru) Производные 1-фенилсульфонил-1,3-дигидро-2h-индол-2-она, их получение и их терапевтическое применение
BR9405988A (pt) Derivados da dialotriazolpirimidina como fungicidas
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
EA200000682A1 (ru) Новые ацилгуанидиновые производные в качестве ингибиторов резорбции костной ткани и антагонистов витронектиновых рецепторов
FI850078A0 (fi) N-(4-piperidinyl)-bicykliska -kondenserade 2-imidazolaminderivat.
DK1029853T3 (da) Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler
ES2145275T3 (es) Derivados de piperazina como antagonistas 5-ht1a.
MX11031A (es) Proceso para la preparacion de nuevas 1-fenil-3-naftaleniloxipropanaminas producto obtenido y composicion farmaceutica que lo incluye.
CO4820432A1 (es) Composiciones farmaceuticas para el tratamiento de rinitis que comprenden acido 2-(4-(difenilmetil)-1-piperacinil)-ace- tico o amida derivada y un compuesto seleccionado de pseudoe fedrina,fenilpropanolamina y fenilefrina
EA200200774A1 (ru) Новые соединения, обладающие гиполипидемической, гипохолестеринемической активностью, способ их получения и содержащие их композиции
PE20040698A1 (es) Derivados de isoindolina
ES2104841T3 (es) Fosfono-aminoacidos bencimidazolicos.
ES2114721T3 (es) Procedimiento para preparar intermedios derivados del acido benzoico y agentes farmaceuticos benzotiofenos.
ATE268337T1 (de) C11-carbamate von antibakteriellen makroliden
PT1026167E (pt) Derivados triciclicos de triazolbenzazepina processo para a sua preparacao e agentes anti-alergicos
EE04496B1 (et) Tetrahüdro-gamma-karboliinid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad kompositsioonid
ATE144508T1 (de) 5-amino-8-methyl-7-pyrrolidinylchinolin-3- carbonsäurederivat
ATE141606T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung
DE19850131A1 (de) Chromenon- und Chromanonderivate
UY24697A1 (es) Metodos para producir inhibidores de vih-proteasa y productos intermedios para producir inhibidores de vih-proteasa
FR2804958B1 (fr) Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 699673

Country of ref document: ES